InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2022 to Q1 2025

Type / Class
Equity / Common Shares, no par value
Symbol
INM on Nasdaq
Shares outstanding
804,525
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
YA II PN, Ltd. 10% $14,885 80,372 YA II PN, Ltd. 13 Dec 2024

Institutional Holders of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$5 0
2024 Q4 0 $0 -$265,983 0
2024 Q3 1,141,865 $265,983 +$152,049 $0.24 12
2024 Q2 440,244 $116,623 -$95,797 $0.27 10
2024 Q1 685,852 $249,191 -$42,696 $0.36 14
2023 Q4 804,163 $334,349 +$315,907 $0.42 13
2023 Q3 26,865 $18,551 +$7,235 $0.69 8
2023 Q2 15,650 $14,412 -$91,568 $0.92 7
2023 Q1 100,918 $109,292 -$123,996 $1.08 12
2022 Q4 115,828 $234,169 -$203,650 $2.00 11
2022 Q3 132,993 $876,125 +$876,125 $6.58 8